is an innovation and investment house focused on the invention, creation, and monetization of proprietary medical technologies that solve major health challenges and revolutionize patient care.
We are the inventors and owners of our patents, transforming brilliant ideas into disruptive products that solve the most pressing market needs while maximizing stakeholder value. Together with our portfolio companies, we have filed over 284 patent applications, of which 103 are already granted.
MAXIMIZING OUR PORTFOLIO’S SUCCESS POTENTIAL THROUGH EXPERT HANDS-ON INVOLVEMENT AND CONTINUOUS MARKET VALIDATION
a unique model of true collaboration and resource-sharing among our portfolio companies. We provide expert hands-on guidance in business, R&D, clinical and regulation, IT, finance, legal, and business development as well as on-going market validation through our business connections with leading KOL’s and strategic partners worldwide. Our lean, streamlined model allows for both capital efficiency and time efficiency – cutting costs and expediting processes like no one else, while helping our portfolio companies meet their goals faster and maximize their potential.
in early-stage medical technologies with projected markets in excess of $1B and the highest ROI potential.